Found: 4
Select item for more details and to access through your institution.
Are the Clinical Course and Drug Toxicity Different in Late-Onset Inflammatory Bowel Disease Patients? From Tertiary Reference Center Real-Life Data.
- Published in:
- Journal of Enterocolitis, 2024, v. 3, n. 1, p. 1, doi. 10.14744/Jenterocolitis.2024.240769
- By:
- Publication type:
- Article
Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?
- Published in:
- Turkish Journal of Gastroenterology, 2022, v. 33, n. 3, p. 196, doi. 10.5152/tjg.2022.211113
- By:
- Publication type:
- Article
Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study.
- Published in:
- Balkan Medical Journal, 2023, v. 40, n. 3, p. 182, doi. 10.4274/balkanmedj.galenos.2023.2022-10-13
- By:
- Publication type:
- Article
Predictors of eligibility for reimbursement of antiviral treatment in HBe-Ag negative chronic hepatitis B patients with high ALT levels.
- Published in:
- Journal of Surgery & Medicine (JOSAM), 2022, v. 6, n. 7, p. 705, doi. 10.28982/josam.1012592
- By:
- Publication type:
- Article